Bolt Biotherapeutics, Inc. (BOLT) — DEF 14A Filings
All DEF 14A filings from Bolt Biotherapeutics, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Bolt Biotherapeutics Files Definitive Proxy Statement
— Apr 25, 2025 Risk: low
Bolt Biotherapeutics, Inc. filed its definitive proxy statement on April 25, 2025, for the fiscal year ending December 31, 2024. The filing pertains to the comp -
Bolt Biotherapeutics Files Preliminary Proxy Statement
— Apr 15, 2025 Risk: low
Bolt Biotherapeutics, Inc. filed a preliminary proxy statement on April 15, 2025, for its annual meeting on May 27, 2025. The company, previously known as Bolt -
Bolt Biotherapeutics, Inc. Announces 2024 Annual Meeting of Stockholders on June 12
— Apr 26, 2024 Risk: low
Bolt Biotherapeutics, Inc. (BOLT) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual Meeting of Stockholders for Bolt Biotherapeu
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX